The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China

Clinical trial NCT06586801 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06586801
Sponsor: Shanghai East Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2024-09-20
Primary completion: 2025-05-10
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.